MY allschoolabs NIG LTD IS THE FOREMOST SUPPLIER OF ZOLADEX LA 3.6 MG IN NIGERIA.

ZOLADEX

What Is Zoladex?
Zoladex 3.6 (goserelin acetate implant) is a man-made form of a hormone used in men to treat symptoms of prostate cancer, and in women to treat breast cancer or endometriosis. Zoladex 3.6 is also used in women to prepare the lining of the uterus for endometrial ablation (a surgery to correct abnormal uterine bleeding). Zoladex 3.6 treats only the symptoms of prostate cancer but does not treat the cancer itself.
What Are Side Effects of Zoladex?

swelling of your face, lips, tongue, or throat,
pain, bruising, swelling, redness, oozing, or bleeding where the implant was injected,
increased thirst,
increased urination,
hunger,
dry mouth,
fruity breath odor,
drowsiness,
dry skin,
weight loss,
nausea,
vomiting,
constipation,
increased thirst or urination,
confusion,
tiredness,
restlessness,
sweating,
back pain,
muscle weakness,
severe numbness or tingling in your legs or feet,
sudden numbness or weakness (especially on one side of the body),
sudden severe headache,
slurred speech, and
problems with vision or balance

INDICATIONS
Stage B2-C Prostatic Carcinoma
Prostatic Carcinoma
Endometriosis
Endometrial Thinning
Advanced Breast Cancer

DRUG INTERACTIONS
No formal drug-drug interaction studies have been performed. No confirmed interactions have been reported between ZOLADEX and other drugs.
Drug/Laboratory Test Interactions
Administration of ZOLADEX in therapeutic doses results in suppression of the pituitary-gonadal system. Because of this suppression, diagnostic tests of pituitary-gonadotropic and gonadal functions conducted during treatment and until the resumption of menses may show results which are misleading. Normal function is usually restored within 12 weeks after treatment is discontinued.

OVERDOSE
The pharmacologic properties of ZOLADEX and its mode of administration make accidental or intentional overdosage unlikely. There is no experience of overdosage from clinical trials. Animal studies indicate that no increased pharmacologic effect occurred at higher doses or more frequent administration. Subcutaneous doses of the drug as high as 1 mg/kg/day in rats and dogs did not produce any nonendocrine related sequelae; this dose is up to 250 times the estimated human daily dose based on the body surface area. If overdosage occurs, it should be managed symptomatically.
CONTRAINDICATIONS
Hypersensitivity
Anaphylactic reactions to ZOLADEX have been reported in the medical literature. ZOLADEX is contraindicated in those patients who have a known hypersensitivity to GnRH, GnRH agonist analogues or any of the components in ZOLADEX.
Pregnancy
ZOLADEX is contraindicated during pregnancy unless ZOLADEX is being used for palliative treatment of advanced breast cancer. ZOLADEX can cause fetal harm when administered to a pregnant woman. If this drug is used during pregnancy, the patient should be apprised of the potential hazard to the fetus. There is an increased risk for pregnancy loss due to expected hormone changes that occur with ZOLADEX treatment [see Use In Specific Populations].

HURRY NOW WHILE STOCK LASTS!!!

 
Share ThisFacebookTwitterWhatsAppPinterestShare This